(VIANEWS) – NEOEN (NEOEN.PA), KONGSBERG GRUPPEN (KOG.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NEOEN (NEOEN.PA)
48.5% sales growth and 7.39% return on equity
Neoen S.A., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. The company operates through Solar Power, Wind Power, Storage, Farm-Down, Development and Investments, and Eliminations segments. It operates in Argentina, Australia, Canada, Ecuador, the United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, NEOEN has a trailing twelve months EPS of €1.14.
PE Ratio
NEOEN has a trailing twelve months price to earnings ratio of 21.79. Meaning, the purchaser of the share is investing €21.79 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.39%.
More news about NEOEN.
2. KONGSBERG GRUPPEN (KOG.OL)
34.5% sales growth and 25.67% return on equity
Kongsberg Gruppen ASA, together with its subsidiaries, provides high-tech systems and solutions primarily to customers in the maritime and defense markets. The company operates through three segments: Kongsberg Maritime, Kongsberg Defence & Aerospace, and Other. The Kongsberg Maritime segment offers solutions and systems for bridge and control systems, which include dynamic positioning, propulsion control, and navigation, as well as automation systems; energy solutions and ship design services; and propellers, thrusters, water jet systems, and systems for offshore manoeuvring of maritime vessels. This segment also provides winches for mooring, anchor handling, and special systems for offshore vessels, tugs, marine vessels, and various other classes of vessel, as well as cranes; hydroacoustics; autonomous underwater vessels and solutions for autonomous maritime vessels; and products related to fisheries, systems for underwater mapping, and sensors and solutions for specialist vessels. The Kongsberg Defence & Aerospace segment offers various systems and services to the defense industry. It provides air defense and combat systems, sonars, and navigation for marine vessels and submarines, as well as integrated command and control systems; remote tower solutions for airports; remote control weapon stations for land-based vehicles and marine vessels; products for military tactical communication; naval strike and air-to-surface missiles; and lightweight composite and titanium components for F-35 combat aircraft. This segment also offers components and services to the space industry, as well as port monitoring systems; and maintenance, repair, and overhaul services. The Other segment focuses on digitalization within the oil and gas, wind, and merchant marine markets. It operates primarily in Norway, Europe, North America, South America, Asia, Australia, and Africa. Kongsberg Gruppen ASA was founded in 1814 and is headquartered in Kongsberg, Norway.
Earnings Per Share
As for profitability, KONGSBERG GRUPPEN has a trailing twelve months EPS of kr20.1.
PE Ratio
KONGSBERG GRUPPEN has a trailing twelve months price to earnings ratio of 32.59. Meaning, the purchaser of the share is investing kr32.59 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.67%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
KONGSBERG GRUPPEN’s EBITDA is 45.79.
More news about KONGSBERG GRUPPEN.
3. NAVAMEDIC (NAVA.OL)
20.7% sales growth and 11.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 31.36. Meaning, the purchaser of the share is investing kr31.36 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51.9%, now sitting on 502.65M for the twelve trailing months.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.00 at 01:20 EST, way under its 52-week high of kr43.90 and way above its 52-week low of kr31.00.
Moving Average
NAVAMEDIC’s worth is below its 50-day moving average of kr37.62 and under its 200-day moving average of kr37.33.
Sales Growth
NAVAMEDIC’s sales growth is 19% for the present quarter and 20.7% for the next.
More news about NAVAMEDIC.
4. HOLLAND COLOURS (HOLCO.AS)
13.8% sales growth and 6.75% return on equity
Holland Colours N.V., together with its subsidiaries, manufactures, distributes, and sells color concentrates in Europe, the Middle East, India, Africa, the Americas, and Asia. The company offers colorants for the building and construction industry, including profiles, pipes, tubing and fittings, siding and cladding, decking, fencing, window blinds, and insulation, as well as solutions for a range of polymers. It also provides colorants for packaging applications comprising water, carbonated soft drinks, fruit juices, dairy, beer, wine, detergents, pharmaceutical, and personal care products. In addition, the company offers coatings, sealants, or adhesives; and colorants for other markets, such as shopping bags, polybags, mulch films, OPP tapes, PU flexible foams, synthetic leather, fiber glass and buttons, paving blocks, artificial stones, cast PMMA, PP non-woven and spunbond, coatings, flexible PVCs, prosthetics, glass fiber reinforced nylon, and silicone rubber and elastomers. It sells its products through a network of agents and distributors. The company was founded in 1979 and is headquartered in Apeldoorn, the Netherlands. Holland Colours N.V. is a subsidiary of Holland Pigments BV.
Earnings Per Share
As for profitability, HOLLAND COLOURS has a trailing twelve months EPS of €4.68.
PE Ratio
HOLLAND COLOURS has a trailing twelve months price to earnings ratio of 19.76. Meaning, the purchaser of the share is investing €19.76 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.75%.
Moving Average
HOLLAND COLOURS’s worth is above its 50-day moving average of €89.55 and below its 200-day moving average of €97.83.
Yearly Top and Bottom Value
HOLLAND COLOURS’s stock is valued at €92.50 at 01:20 EST, way below its 52-week high of €132.00 and way above its 52-week low of €82.00.
Volume
Today’s last reported volume for HOLLAND COLOURS is 10 which is 91.37% below its average volume of 116.
More news about HOLLAND COLOURS.
